1. {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":37,"cheight":29,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500727.png","picWidth":40,"picHeight":29,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

          聯系電話:0851-33411018(行政部)   0851-88173360(銷售部)    股票代碼:SZ 002424

          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":550,"cheight":381,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889249.png","picWidth":550,"picHeight":381,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
          州百靈企業集團制藥股份有限公司
          股票代碼:SZ 002424
          查看更多最新公告>
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":634,"cheight":56,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500733.png","picWidth":630,"picHeight":56,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

          走進百靈

          專精于藥 · 專注于人

           貴州百靈企業集團制藥股份有限公司(以下簡稱“貴州百靈”)是一家從事苗藥研發、生產、銷售于一體的醫藥上市公司,注冊資本14.112億元,總資產70.59億元,員工6124人。2010年6月,公司在深圳證券交易所成功上市(股票代碼:SZ 002424)。公司明確圍繞“強化公司在苗藥領域的優勢地位,力爭成為中成藥領域具有核心競爭優勢的企業”為戰略發展目標,以實施“科技苗藥、文化苗藥、生態苗藥”為抓手,致力打造擁有大健康全產業鏈的企業集團。

          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":365,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集團概況","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889219.png","picWidth":360,"picHeight":129,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集團概況","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集團概況","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889221.png","picWidth":"373","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集團概況","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"藥材基地","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889220.png","picWidth":"363","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"藥材基地","linkKey":"page","linkUrl":"page.html?id=675381845688358","jsonData":{}}}
          致力于推動苗藥品種的科研創新
          實現傳統苗藥現代化、科技化

          持續挖掘和探索苗藥寶庫,以傳承

          和發揚民族醫藥文化為企業使命

          布局中藥材種植產業,加強道地

          藥材保護,助力產業化精準扶貧

          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":754,"picHeight":61,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

          產品與服務

          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":752,"picHeight":61,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
          • 非處方藥
          • 處方藥
          • 大健康產品
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":591,"cheight":57,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500734.png","picWidth":590,"picHeight":57,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

          百靈動態

          關注百靈了解更多最新資訊

          • 百靈新聞
          • 媒體聚焦
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":264,"cheight":161,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=950846292492375","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/956068561682543.jpeg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=950846292492375","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=950846292492375","jsonData":{}}}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":272,"cheight":161,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=950846292492378","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/956068561682553.jpeg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=950846292492378","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=950846292492378","jsonData":{}}}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":278,"cheight":162,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865548","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/956068570071050.jpg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=944654853865548","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865548","jsonData":{}}}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":300,"cheight":164,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865544","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399231570022.jpg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=944654853865544","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865544","jsonData":{}}}

          貴州百靈向畢節市大方方艙醫院捐贈24000瓶“咳速停糖漿”

          共抗疫情,風雨同舟——貴州百靈捐贈價值280萬元“咳速停糖漿”馳援西藏

          奮楫爭先顯風采 競聘就崗選英才——貴州百靈銷售部首次公開競聘活動順利舉辦

          貴州百靈參股公司賾靈生物“注射用甲磺酸普依司他”治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床

          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":20,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"22","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":20,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"20","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":22,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"22","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":21,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"21","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

          2022-09-23

          2022-09-22

          2022-09-07

          2022-09-02

          9月2日,貴州百靈企業集團總部,隨著最后一項現場PK環節的終場哨響起,貴州百靈銷售部為期半個月的管理人員公開競聘活動正式落下帷幕。8月19日以來,根據集團戰略發展要求,為有效推動人才梯隊建設,保障并促進整體經營戰略目標的實現詳細>

          8月31日晚間,貴州百靈發布參股子公司在研項目進展公告,賾靈生物近日收到《四川大學華西醫院臨床試驗倫理審查委員會批件》,同意公司開展“注射用甲磺酸普依司他”治療復發或難治彌漫大B細胞淋巴瘤(R/R DLBCL)的有效性和安全性的開放性、多中心Ⅱ期臨床研究詳細>

          為進一步支援西藏地區疫情防控工作,攜手同心,共克時艱,9月6日以來,貴州百靈企業集團千里馳援,向西藏拉薩市、日喀則市等疫情較為嚴重的地區分批捐贈防疫藥品“咳速停糖漿”3200件…詳細>

          為積極支援貴州省內疫情防控工作,同心抗疫,共度時艱,9月22日,貴州百靈企業集團向安順市紅十字會捐贈防疫藥品24000瓶“咳速停糖漿”(價值約47.5萬元),定向用于畢節市大方方艙醫院的臨床救治和疫情防控一線…詳細>

          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":272,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865590","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399231570033.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=944654853865590","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865590","jsonData":{}}}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":280,"cheight":180,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=944654837088361","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399055409194.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=944654837088361","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=944654837088361","jsonData":{}}}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":300,"cheight":200,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"中國證券報 | 貴州百靈:甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399231570022.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"中國證券報 | 貴州百靈:甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床","linkUrl":"中國證券報 | 貴州百靈:甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床","jsonData":{}}}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":268,"cheight":163,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=944654837088275","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399038632043.jpg","picWidth":"300","picHeight":"366","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=944654837088275","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=944654837088275","jsonData":{}}}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

          2022-09-23

           

          2022-09-15

          2022-09-03

          2022-08-29

          上海證券報 | 貴州百靈上半年業績逆勢小幅增長 糖寧通絡國家課題等獲重大進展

          {"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":751,"cheight":64,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889216.png","picWidth":751,"picHeight":64,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

          投資者關系

          與您共享貴州百靈的發展和成績

          俄罗斯老妇禽交rd 又粗又大又黄又爽的免费视频 香蕉久久一区二区不卡无毒影院 久久久久久精品免费免费自慰 91人妻中文字幕无码专区 午夜性色福利视频 精品久久久久久亚洲国产18 黄色视频视频网站 黑人上司粗大拔不出来 国产在线视频黄片 91色偷偷色噜噜狠狠爱网站